Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02903407 · ClinicalTrials.gov registry record · Phase 4
Pain, Agitation and Delirium (PAD) Protocol in the Duke CICU
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT02903407 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 7 participants.
The verdict
NCT02903407, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study aims to examine the use of protocol directed sedation using the Duke PAD protocol with the current sedation medications of propofol or dexmedetomidine compared to the PAD protocol with midazolam, per cardiac intensive care unit (CICU) usual care, as an initial step toward understanding the best management of sedation in these patients.
Interventions
- DRUG Midazolam
- DRUG Dexmedetomidine
- DRUG Propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2019-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02903407
The ClinicalTrials.gov registry entry for NCT02903407 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Midazolam is the first listed.
NCT02903407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02903407 about?
NCT02903407 is a clinical study titled "Pain, Agitation and Delirium (PAD) Protocol in the Duke CICU". This study aims to examine the use of protocol directed sedation using the Duke PAD protocol with the current sedation medications of propofol or dexmedetomidine compared to the PAD protocol with midazolam, per cardiac intensive care unit (CICU) usual care, as an initial step toward understanding th...
What is the current status of trial NCT02903407?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2017-09-01. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT02903407?
The interventions under investigation include: Midazolam (DRUG), Dexmedetomidine (DRUG), Propofol (DRUG).
Who is sponsoring clinical trial NCT02903407?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.